• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    Health experts worried about high mutations in new COVID-19 variant

    The variant has over 30 mutations in its spike protein — raising concerns about heightened infectiousness.

    By Sara Jerving // 25 November 2021
    A health worker looks on inside the Transvaco COVID-19 vaccine train, which aims to help the government speed up its vaccine rollout in South Africa’s remote communities. Photo by: Siphiwe Sibeko / Reuters

    A new COVID-19 variant originally found in Botswana, and now present in South Africa and Hong Kong, is causing concern among health experts due to its unusually high level of mutations.

    “This is quite a concern globally, and also it is quite a concern, especially in the southern part of the [African] continent,” said Dr. Nicksy Gumede-Moeletsi, a virologist for the World Health Organization's regional office in Africa.

    Impacts on infectiousness: The new variant, known as B.1.1529, has over 30 mutations in the spike protein. Professor Francois Balloux, director of the UCL Genetics Institute in the United Kingdom, said in a statement the variant carries “an unusual constellation of mutations” and “likely evolved during a chronic infection of an immunocompromised person, possibly in an untreated HIV/AIDS patient.”

    These mutations might have implications for how infectious it is, said Gumede-Moeletsi. “It might even make it harder for the immune cells to be able to detect the virus,” she said.

    Gumede-Moeletsi said she is concerned this variant is emerging in the lead-up to the holiday season, when people cross borders to visit family. Last year, a new variant was also reported in South Africa right before the holidays.

    Tulio de Oliveira, director of the Centre for Epidemic Response and Innovation in South Africa said the variant has “rapidly increased” in Gauteng province, where Johannesburg is located, and “may already be present in most provinces” in the country.

    ‘No need to panic’: Health officials say more information is needed to know the significance of these mutations. South Africa’s National Institute for Communicable Diseases tweeted: “Viruses change through mutation, and new variants of a virus like the novel coronavirus are expected to occur over time. There is therefore no need to panic.”

    More reading:

    ► Concerns mount that a new COVID-19 variant could be spreading in Africa

    ► Research suggests malaria exposure could reduce COVID-19 severity

    • Global Health
    • Research
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      Supporting community-driven solutions to address breast cancer
    • 5
      No health reform without better AI governance
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement